Cardiovascular Metrics
ViiV gains US approval for newborn HIV treatment
Newborn HIV treatment gets US FDA approval as ViiV's Tivicay PD becomes the first second‑gen INSTI cleared for infants 2 kg or heavier, widening options.
By Ava Brown · Aug 29, 2026